Adherence to anticoagulant treatment with dabigatran in a real‐world setting

ConclusionIn our clinical practice adherence to the twice‐daily dabigatran regimen was generally good, although 12% of the patients had an inadequate adherence. Routine feedback from the pharmacies could inform the physician to improve the anticoagulant management.This article is protected by copyright. All rights reserved.

Source: Journal of Thrombosis and Haemostasis - April 13, 2013 Category: Hematology Authors: S. Schulman, B. Shortt, M. Robinson, J. W. Eikelboom Tags: Original Article ‐ Clinical Haemostasis and Thrombosis Source Type: research